Research Article
Volume 11 Issue 9 - 2020
Ophthalmological Symptoms, Evaluation and Diagnoses in Parkinson’s Disease
Marta Fabrykowski1,2, Alessandro Di Rocco2 and Jamie Mitchell1,2*
1Department of Ophthalmology, Manhattan Eye Ear and Throat Hospital, New York, United States
2Department of Neurology, Lenox Hill Hospital, New York, United States
*Corresponding Author: Jamie Mitchell, Department of Ophthalmology, Manhattan Eye Ear and Throat Hospital and Department of Neurology, Lenox Hill Hospital, New York, United States.
Received: July 22, 2020; Published: August 31, 2020




Abstract

Objective: To evaluate ophthalmologic symptoms in Parkinson’s Disease patients, the frequency of referral to ophthalmology for these symptoms and the variability in ophthalmologic assessment and diagnosis.

Design: Retrospective case series from January 2016 to December 2018.

Setting: Northwell affiliated primary care and referral centers.

Participants: Parkinson’s Disease patients with a documented ophthalmologic complaint between January 2016 and December 2018.

Exposures: Clinical ophthalmologic assessment for referred patients.

Main Outcomes and Measures: Rate of ophthalmology referral in Parkinson’s patients with eye related complaints, most common ocular symptoms and diagnosis. We also examined the frequency of ophthalmologic testing including manifest refraction, near vision assessment, oculomotor exam and optical coherence tomography.

Results: 123 of the 345 Parkinson’s Disease patients with documented ocular or visual complaint were subsequently seen by ophthalmology, 64 males and 59 females with a mean age of 76.1 +/- 7.78. The most common symptoms included blurry vision (72%), difficulty reading (72%), ocular discomfort (51%) and double vision (31%). The most common ophthalmological diagnoses included glaucoma (30%), dry eye (28%), and strabismus (22%). There was substantial variability in components of the ophthalmology evaluation, specifically the inclusion of optical coherence tomography (OCT) of the retinal nerve fiber layer (33%), and ganglion cell layer- inner plexiform layer (10%), testing of near vision (37%) and manifest refraction (31%).

Conclusion and Relevance: PD patients with visual complaints are under referred to ophthalmology. Furthermore, once patients are referred, they undergo ophthalmological evaluations that are inconsistent and often not comprehensive. Standards for both referral structure to ophthalmology and ophthalmological assessment are integral for optimal patient care.

Keywords: Parkinson’s Disease; Ocular Complaint; Ophthalmology; Visual Dysfunction; Optical Coherence Tomography

References

  1. Jankovic J. “Parkinson's disease: clinical features and diagnosis”. Journal of Neurology, Neurosurgery, and Psychiatry 4 (2008): 368-376.
  2. Obeso JA., et al. “Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy”. Journal of Movement Disorders 9 (2017): 1264-1310.
  3. Goldman JG and Postuma R. “Premotor and nonmotor features of Parkinson's disease”. Current Opinion in Neurology 4 (2014): 434-441.
  4. Chaudhuri KR., et al. “Parkinson's disease: the non-motor issues”. Parkinsonism and Related Disorders 10 (2011): 717-723.
  5. Armstrong RA. “Visual symptoms in Parkinson's disease”. Parkinson's Disease (2011): 908306.
  6. Ekker MS., et al. “Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked”. Parkinsonism and Related Disorders 40 (2017): 1-10.
  7. Biousse V., et al. “Ophthalmologic features of Parkinson's disease”. Neurology2 (2004): 177-180.
  8. Lawrence BJ., et al. “Activities of daily living, depression, and quality of life in Parkinson's disease”. PLoS One7 (2014): e102294.
  9. Nowacka B., et al. “Ophthalmological features of Parkinson disease”. Medical Science Monitor 20 (2014): 2243-2249.
  10. Aarsland D., et al. “Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study”. Journal of the American Geriatrics Society 8 (2000): 938-942.
  11. Nishijima T., et al. “Routine Eye Screening by an Ophthalmologist Is Clinically Useful for HIV-1-Infected Patients with CD4 Count Less than 200 /μL”. PLoS One9 (2015): e0136747.
  12. Tamer C., et al. “Tear film tests in Parkinson's disease patients”. Ophthalmology10 (2005): 1795.
  13. Chung SD., et al. “Increased risk of Parkinson disease following a diagnosis of neovascular age-related macular degeneration: a retrospective cohort study”. American Journal of Ophthalmology 2 (2014): 464-469.e1.
  14. Matlach J., et al. “Retinal changes in Parkinson's disease and glaucoma”. Parkinsonism and Related Disorders 56 (2018): 41-46.
  15. Weinreb RN., et al. “The pathophysiology and treatment of glaucoma: a review”. The Journal of the American Medical Association 18 (2014): 1901-1911.
  16. AU Bayer., et al. “Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease”. American Journal of Ophthalmology 133 (2002): 135e137.
  17. Yenice O., et al. “Visual field analysis in patients with Parkinson's disease”. Parkinsonism and Related Disorders 3 (2008): 193-198.
  18. Tsironi Evangelia., et al. “Perimetric and retinal nerve fiber layer findings in patients with Parkinson’s disease”. BMC Ophthalmology 12 (2012): 54.
  19. Yu J-g., et al. “Retinal Nerve Fiber Layer Thickness Changes in Parkinson Disease: A Meta-Analysis”. PLoS ONE1 (2014): e85718.
  20. Chrysou A., et al. “Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studies”. Parkinsonism and Related Disorders 64 (2019): 40-49.
  21. Sari ES., et al. “Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration”. Journal of Neuro-Ophthalmology 2 (2015): 117-121.
  22. Ucak T., et al. “Analysis of the retinal neve fiber and ganglion cell-Inner plexiform layer by optical coherence tomography in Parkinson’s patients”. Parkinsonism and Related Disorders (2016): 59-64.
  23. Doustar J., et al. “Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases”. Frontiers in Neurology 8 (2017): 701.
  24. Satue M., et al. “Optical Coherence Tomography as a Biomarker for Diagnosis, Progression, and Prognosis of Neurodegenerative Diseases”. Journal of Ophthalmology (2016): 8503859.
  25. Lepore FE. “Parkinsons disease and diplopia”. Neuro-Ophthalmology 30 (2006): 37-40.
  26. Shibasaki H., et al. “Oculomotor Absnormalities in Parkinson’s Disease”. Archives of Neurology6 (1979): 360-364.
Citation: Jamie Mitchell., et al. “Ophthalmological Symptoms, Evaluation and Diagnoses in Parkinson’s Disease”. EC Ophthalmology 11.9 (2020): 37-45.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 25, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.